Caricamento...
Phase II open label study of valproic acid in spinal muscular atrophy.
UNLABELLED:Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit. We performed an open label trial of VPA in 42 subjects with SMA to as...
Salvato in:
Autori principali: | , , , , , , , , , , , , , , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Public Library of Science (PLoS)
2009-01-01
|
Serie: | PLoS ONE |
Accesso online: | http://europepmc.org/articles/PMC2680034?pdf=render |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|